One more strike against diabetes drugs. Australia's regulators are warning that the class of drugs including Avandia and Actos may boost the risk of bone fractures in older women.
A four-year study of 4,360 patients showed that post-menopausal women taking one of the thiazolidinediones were more likely to break a bone. The Therapeutic Goods Administration won't withdraw the drugs, but manufacturers are warning doctors about the newly identified risks.
- read the report from the Sydney Morning Herald
Related Articles:
Avandia, Actos don't boost death risk. Report
Actos on a good-news roll. Report
Avandia risks back in the headlines. Report
Australia bans Novartis' Prexige. Report